Keywords: approval, patent, delays, hinder, korean, market, multinational

Approval, patent delays hinder Korean market

Article | 21 June 2004

Print This

Multinational drug firms regard Korea's regulatory process as cumbersome and it delays their plans to launch new products, Drees Beekman, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in